Status:
COMPLETED
Improving Rates of Repeat Colorectal Cancer Screening
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
51-75 years
Phase:
NA
Brief Summary
The United States Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening using fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy in adults, beginning at ag...
Eligibility Criteria
Inclusion
- Fecal occult blood test (FOBT) completed in the past year
- Age 51-75
- Preferred language English or Spanish
Exclusion
- Any of the following: (1) Colonoscopy within 10 years (2) Flexible sigmoidoscopy within 5 years or (3) A clinician order or referral for FOBT prior to the due date
- Documentation of medical conditions suggesting colorectal cancer (CRC) screening through FOBT may be inappropriate including: chronic diarrhea, inflammatory bowel disease, iron deficiency, previous colonic polyp, use of medications in the previous 1 month that elevate the risk of a false-positive FOBT
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT01453894
Start Date
March 1 2012
End Date
August 1 2013
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611